MRI accuracy in residual disease evaluation in breast cancer patients treated with neoadjuvant chemotherapy
Authors:
- P. BelliPBP. Belli
- M. CostantiniMCM. Costantini
- C. MalaspinaCMC. Malaspina
- A. MagistrelliAMA. Magistrelli
- G. LaTorreG. LaTorre
- L. BonomoLBL. Bonomo
- 1 November 2006
- journal article
- Published by Elsevier in Clinical Radiology
- Vol. 61 (11) , 946-953
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Imaging in Evaluation of Response to Neoadjuvant Breast Cancer Treatment Benefits of MRIBreast Cancer Research and Treatment, 2002
- MRI of breast cancer: influence of chemotherapy on sensitivity.British Journal of Radiology, 1997
- Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imagingCancer, 1996
- Breast tumors: comparative accuracy of MR imaging relative to mammography and US for demonstrating extent.Radiology, 1995
- Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cmCancer, 1994
- Induction chemotherapy followed by breast conservation for locally advanced carcinoma of the breastCancer, 1994
- Multimodal therapy in locally advanced breast carcinomaThe American Journal of Surgery, 1990
- Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapyCancer, 1988
- Multimodality Treatment of Locally Advanced Breast CarcinomaArchives of Surgery, 1988
- Mastectomy as an Adjuvant to Chemotherapy for Locally Advanced or Metastatic Breast CancerArchives of Surgery, 1982